
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate is well-positioned to succeed in the growing life science industry, with a strong market presence in key locations and a focus on developing, redeveloping, and operating properties for this industry. The company's strategy to pivot away from life science to other uses and potential asset sales should reduce costs and generate revenue earlier than expected, leading to a positive outlook for future growth and profitability. Additionally, the company has a significant backlog and a strong demand backdrop from various sectors, making it an attractive investment opportunity.
Bears say
Alexandria Real Estate is a real estate investment trust (REIT) that specializes in providing office space to life science, agtech, and technology tenants. Despite the company's strong market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, and others, its near-term earnings outlook is uncertain due to planned asset sales and a soft life science leasing environment. With a slower revenue growth trajectory and potentially lower margins, the company's valuation may be impacted, leading to a negative outlook for its stock.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares